Curanex Pharmaceuticals Inc (CURX): Cash & Equivalents

Annual figures by period end, from SEC filings.

$5.00M

As of 2025-12-31

$2.94M

As of 2026-06-30

Period ended	Cash & Equivalents	Change YoY	Source filing
2025-12-31	$5.00M	n/a	2026-03-30, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cash & Equivalents	Change YoY
Curanex Pharmaceuticals Inc (CURX)	2025-12-31	$5.00M	n/a
Revelation Biosciences, Inc. (REVB)	2025-12-31	$10.70M	+64.6%
NewcelX Ltd. (NCEL)	2025-12-31	$2.20M	+238.6%
PRF Technologies Ltd. (PRFX)	2025-12-31	$3.12M	-26.7%
MetaVia Inc. (MTVA)	2025-12-31	$10.28M	-35.8%
Mira Pharmaceuticals, Inc. (MIRA)	2025-12-31	$6.35M	+124.0%
Decoy Therapeutics Inc. (DCOY)	2025-12-31	$10.71M	+339.9%
Anebulo Pharmaceuticals, Inc. (ANEB)	2025-06-30	$11.63M	+275.8%
Lantern Pharma Inc. (LTRN)	2025-12-31	$4.42M	-41.1%

Compare CURX, REVB, NCEL, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗